Changes in regional cerebral blood flow associated with a 45  day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study.

CONCLUSION: Daily ingestion of caprylidene over 45 days was associated with increased blood flow in specific brain regions in patients lacking an apolipoprotein ɛ4 allele. PMID: 30006299 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30006299?dopt=Abstract

Source: Experimental Gerontology - July 10, 2018 Category: Geriatrics Authors: Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, Ossinalde C, Silverman DH Tags: Exp Gerontol Source Type: research

Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study.

Changes in regional cerebral blood flow associated with a 45  day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study.